Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator beambe, BigBake1, LongRun8, TRUTH
Search This Board:
Last Post: 10/31/2014 10:10:38 AM - Followers: 122 - Board type: Free - Posts Today: 0


Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.


President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.


Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.





  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
Option Chain for NVAX
NVAX News: Statement of Changes in Beneficial Ownership (4) 10/06/2014 10:16:37 AM
NVAX News: Statement of Changes in Beneficial Ownership (4) 10/03/2014 04:28:34 PM
NVAX News: Statement of Changes in Beneficial Ownership (4) 09/26/2014 05:03:14 PM
NVAX News: Statement of Changes in Beneficial Ownership (4) 09/26/2014 04:56:39 PM
NVAX News: Current Report Filing (8-k) 09/24/2014 04:16:47 PM
#2037   this is a very good NEWS-thank beambe 10/31/14 10:10:37 AM
#2036 BigBake1 10/31/14 09:58:55 AM
#2035   Novavax also Ebola research? beambe 10/31/14 09:57:45 AM
#2034   I got to say it wasnt the kind BigBake1 10/30/14 02:19:48 PM
#2033   thanks for the INFO beambe 10/30/14 10:50:18 AM
#2032   Novavax to Host Conference Call to Discuss Third BigBake1 10/30/14 09:59:05 AM
#2031   Thanks! jcoukr 10/30/14 09:55:38 AM
#2030   VOLUME beambe 10/30/14 09:47:23 AM
#2029   Yeah I couldnt tell ya, I am sure BigBake1 10/30/14 09:41:38 AM
#2028   Very nice well I might have to buy jcoukr 10/30/14 09:39:06 AM
#2027   Yep, that was what was stated on Monday BigBake1 10/30/14 09:34:25 AM
#2026   Im assuming the clinical trials in December are jcoukr 10/30/14 09:29:06 AM
#2025   No it's Flu vaccine has been fast tracked: BigBake1 10/30/14 09:27:25 AM
#2024   Is yesterdays fda expediting the clinical trials for jcoukr 10/30/14 09:21:54 AM
#2023   Hey glad to see it, I like seeing BigBake1 10/30/14 08:07:38 AM
#2022   Hard to believe but I like companies that jcoukr 10/30/14 08:02:38 AM
#2021   Hey and on a real stock board too... BigBake1 10/30/14 07:55:58 AM
#2020   Pretty certain we had some short covering to BigBake1 10/30/14 07:53:13 AM
#2019   I bought some yesterday but apparently not enough jcoukr 10/30/14 06:52:18 AM
#2018   Interesting! This is great news indeed...! \o/ MRatt 10/29/14 11:45:17 PM
#2017   Yeah tomorrow is gonna be insane with 35M LarsonLE 10/29/14 10:08:45 PM
#2016   It finished at 8pm in aftermarket trading at BigBake1 10/29/14 08:20:58 PM
#2015   That's awesome news. Congrats to NVAX and LongRun8 10/29/14 08:18:02 PM
#2014   Here is the actual Globenewswire link: BigBake1 10/29/14 06:28:44 PM
#2013   that is something quite large beambe 10/29/14 06:15:33 PM
#2012   Bad timing for those that flipped... lol.. Tomorrow BigBake1 10/29/14 05:46:33 PM
#2011   Booommmm.... belgiumsui 10/29/14 05:29:53 PM
#2010   GAITHERSBURG, Md., Oct. 29, 2014 (GLOBE NEWSWIRE) -- belgiumsui 10/29/14 05:29:03 PM
#2009   NVAX on my radar HisWill77 10/29/14 06:46:39 AM
#2008   This company will be doing real well against BiotehPickList 10/28/14 09:35:17 AM
#2007   This is going to 6 Tuesday maybe then ALL IN2 10/27/14 09:44:58 PM
#2006   it is faster beambe 10/27/14 06:46:59 PM
#2005 beambe 10/27/14 06:44:33 PM
#2004 beambe 10/27/14 06:42:54 PM
#2003   thank you beambe 10/27/14 06:42:01 PM
#2002   Volume beambe 10/27/14 06:38:10 PM
#2001   * * $NVAX Video Chart 10-27-14 * * ClayTrader 10/27/14 04:55:14 PM
#2000   Thanks BigBake1, great video -> info! MRatt 10/27/14 03:14:50 PM
#1999   yes it is, still moving up! NVAX rivervalley 10/27/14 02:55:46 PM
#1998   Yeah it was the CEO Erck: BigBake1 10/27/14 02:45:08 PM
#1997   I should have, but I currently have way underdog150 10/27/14 02:44:24 PM
#1996   The reason for this afternoons surge in volume BigBake1 10/27/14 02:40:14 PM
#1995   $NVAX Is SO STRONG! ;) MRatt 10/27/14 02:34:24 PM
#1994   5.72 new HOD rivervalley 10/27/14 02:16:28 PM
#1993   Did you get any $6 November calls? BigBake1 10/27/14 02:13:01 PM
#1992   Pre market is putting that gap between $5.75 BigBake1 10/27/14 08:21:35 AM
#1991   Ebola news underdog150 10/27/14 08:14:33 AM
#1990   Stock is up 8% in pre market on BigBake1 10/27/14 08:13:45 AM
#1989   Could be huge news if RSV Vaccine proves Kraken3 10/24/14 12:48:16 PM
#1988   A think a combination of things has pushed BigBake1 10/17/14 09:28:55 AM